Next Article in Journal
Prospective Role of Bioactive Molecules and Exosomes in the Therapeutic Potential of Camel Milk against Human Diseases: An Updated Perspective
Previous Article in Journal
NSD1 Mutations in Sotos Syndrome Induce Differential Expression of Long Noncoding RNAs, miR646 and Genes Controlling the G2/M Checkpoint
Previous Article in Special Issue
Classification of Dystonia
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Dystonia: Still a Mysterious Syndrome

by
Ryoma Morigaki
1,2,3,* and
Ryosuke Miyamoto
3,4
1
Department of Advanced Brain Research, Institute of Biomedical Sciences, Graduate School of Medicine, Tokushima University, 3-18-15 Kuramoto-Cho, Tokushima 770-8503, Tokushima, Japan
2
Department of Neurosurgery, Institute of Biomedical Sciences, Graduate School of Medicine, Tokushima University, 3-18-15 Kuramoto-Cho, Tokushima 770-8503, Tokushima, Japan
3
Parkinson’s Disease and Dystonia Research Center, Tokushima University Hospital, 2-50-1 Kuramoto-Cho, Tokushima 770-8503, Tokushima, Japan
4
Department of Neurology, Institute of Biomedical Sciences, Graduate School of Medicine, Tokushima University, 3-18-15 Kuramoto-Cho, Tokushima 770-8503, Tokushima, Japan
*
Author to whom correspondence should be addressed.
Life 2022, 12(7), 989; https://doi.org/10.3390/life12070989
Submission received: 29 June 2022 / Accepted: 29 June 2022 / Published: 4 July 2022
(This article belongs to the Special Issue Dystonia and Related Disorders: From Bench to Bedside)
The diagnosis of dystonia is sometimes complicated due to its many clinical manifestations, causes, and the lack of specific diagnostic examinations or simple algorithms [1,2,3,4]. In this Special Issue, Biase et al. updated a dystonia classification algorithm based on phenomenology, which could be useful to movement disorder specialists [5]. Although recent developments in AI-based deep learning technology offer highly accurate diagnostic tools in neuroimaging [6], clinical phenomenology, mainly motor manifestations, remains the gold standard for diagnosing dystonia.
The importance of clinical phenomenology in the diagnosis of dystonia is similar to that of psychiatric diseases. Interestingly, dystonic movements in Oppenheim’s dystonia were thought to be psychogenic before the discovery of the DYT1 (Tor1A) gene [7,8]. Currently, dystonia is recognized as an organic disease, mainly due to dysfunction of the brain motor circuit; however, psychiatric comorbidities are often discussed [9]. From a psychiatric point of view, functional neurological disorders, including functional dystonia, a psychiatric disease defined in the DSM-5, make it difficult to distinguish organic dystonia from psychiatric disorders [10]. For discrimination purposes, a highly accurate diagnostic algorithm based on the phenomenological features of functional dystonia was developed [11], and a neuroimage-based diagnostic tool was investigated [12,13,14]. These attempts have uncovered the pathogenesis of functional dystonia, which might also be a brain circuit disorder. However, similar to organic dystonia, phenomenological features are still the gold standard for diagnosing functional dystonia, and the personality profiles in patients with dystonia seem to be unique, novel, and important [15]. Regardless of its significance, the personality profile is largely unknown and might be important for clinicians considering treatment strategies.
In addition to medication therapy, pallidal deep brain stimulation (DBS) surgery is a promising treatment for medically intractable primary dystonia, which involves the cortico–basal ganglia–thalamocortical motor loop in its pathogenesis [16,17]. Jamora et al. showed the efficacy of lesioning the pallidothalamic tract using focused transcranial MR-guided ultrasound in dystonia patients with DYT3/XDP-TAF1, suggesting the involvement of the cortico–basal ganglia–thalamocortical loop in the pathogenesis of DYT3/XDP-TAF1 dystonia [18]. Goto et al. proposed a striatal compartmental hypothesis in the pathogenesis of dystonia, which may affect the cortico–basal ganglia–thalamocortical loop [19]. This hypothesis was derived from neuropathological findings in patients with DYT3/XDP-TAF1. According to this theory, striatal striosome compartment dysfunction may cause dystonia. Interestingly, the striosome compartment receives variable input from limbic-system-related cortices [20], which might account for psychiatric comorbidities. The striosome compartment could be a hub structure for interference between the motor and limbic functional loops, and we cannot deny the co-existence of organic and functional components in patients with dystonia [21].
The efficacy of pallidal-DBS varies in secondary dystonia. Pallidal-DBS is highly effective for tardive dystonia, even in the long term [22]. In contrast, some conditions, such as tonic-type dystonia, which is manifested in cerebral palsy, showed relatively lower improvement with pallidal-DBS [23]. Recently, DBS of the deep cerebellar nuclei or superior cerebellar peduncle has been reported to be effective in patients with tonic-type dystonia [24,25,26]. In addition to the compartmental hypothesis, accumulating evidence suggests that cerebellar dysregulation might be a critical element in the genesis of dystonia [27]. It is still unclear whether both the cortico–ponto–cerebello–thalamocortical and cortico–basal ganglia–thalamocortical loops are necessary for dystonia genesis. The complicated mixture of several components might account for the phenomenological diversity of dystonia and make it difficult for clinicians and researchers to elucidate the underlying cause. Dystonia is still one of the most mysterious syndromes, and much remains to be elucidated for better treatment and outcomes.

Funding

This work was supported in part by JSPS KAKENHI Grant Numbers JP16KK0182 and JP20K17932 and Japan Agency for Medical Research and Development (AMED Number 16ek0109182h0001).

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the writing of or in the decision to publish the manuscript.

References

  1. Hallett, M. Functional movement disorders: Is the crisis resolved? Mov. Disord. 2019, 34, 971–974. [Google Scholar] [CrossRef] [PubMed]
  2. Jinnah, H.A.; Factor, S.A. Diagnosis and treatment of dystonia. Neurol. Clin. 2015, 33, 77–100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Albanese, A.; Asmus, F.; Bhatia, K.P.; Elia, A.E.; Elibol, B.; Filippini, G.; Gasser, T.; Krauss, J.K.; Nardocci, N.; Newton, A.; et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur. J. Neurol. 2011, 18, 5–18. [Google Scholar] [CrossRef] [PubMed]
  4. Geyer, H.L.; Bressman, S.B. The diagnosis of dystonia. Lancet Neurol. 2006, 5, 780–790. [Google Scholar] [CrossRef]
  5. Di Biase, L.; Di Santo, A.; Caminiti, M.L.; Pecoraro, P.M.; Di Lazzaro, V. Classification of Dystonia. Life 2022, 12, 206. [Google Scholar] [CrossRef]
  6. Valeriani, D.; Simonyan, K. A microstructural neural network biomarker for dystonia diagnosis identified by a DystoniaNet deep learning platform. Proc. Natl. Acad. Sci. USA 2020, 117, 26398–26405. [Google Scholar] [CrossRef]
  7. Edwards, M.J.; Bhatia, K.P. Functional (psychogenic) movement disorders: Merging mind and brain. Lancet Neurol. 2012, 11, 250–260. [Google Scholar] [CrossRef]
  8. Munts, A.G.; Koehler, P.J. How psychogenic is dystonia? Views from past to present. Brain 2010, 133 Pt 5, 1552–1564. [Google Scholar] [CrossRef] [Green Version]
  9. Zurowski, M.; McDonald, W.M.; Fox, S.; Marsh, L. Psychiatric comorbidities in dystonia: Emerging concepts. Mov. Disord. 2013, 28, 914–920. [Google Scholar] [CrossRef]
  10. Baizabal-Carvallo, J.F.; Hallett, M.; Jankovic, J. Pathogenesis and pathophysiology of functional (psychogenic) movement disorders. Neurobiol. Dis. 2019, 127, 32–44. [Google Scholar] [CrossRef]
  11. Stephen, C.D.; Perez, D.L.; Chibnik, L.B.; Sharma, N. Functional dystonia: A case-control study and risk prediction algorithm. Ann. Clin. Transl. Neurol. 2021, 8, 732–748. [Google Scholar] [CrossRef] [PubMed]
  12. Hallett, M.; Aybek, S.; Dworetzky, B.A.; McWhirter, L.; Staab, J.P.; Stone, J. Functional neurological disorder: New subtypes and shared mechanisms. Lancet Neurol. 2022, 21, 537–550. [Google Scholar] [CrossRef]
  13. Conejero, I.; Thouvenot, E.; Abbar, M.; Mouchabac, S.; Courtet, P.; Olie, E. Neuroanatomy of conversion disorder: Towards a network approach. Rev. Neurosci. 2018, 29, 355–368. [Google Scholar] [CrossRef] [PubMed]
  14. Conejero, I.; Collombier, L.; Lopez-Castroman, J.; Mura, T.; Alonso, S.; Olie, E.; Boudousq, V.; Boulet, F.; Arquizan, C.; Boulet, C.; et al. Association between brain metabolism and clinical course of motor functional neurological disorders. Brain 2022, awac146. [Google Scholar] [CrossRef]
  15. Davidescu, E.I.; Odajiu, I.; Tulba, D.; Mitrea, I.; Cucu, C.; Popescu, B.O. Psychological Traits and Behavioural Influences in Patients with Dystonia-An Observational Cohort Study in a Romanian Neurology Department. Life 2021, 11, 612. [Google Scholar] [CrossRef]
  16. Vidailhet, M.; Vercueil, L.; Houeto, J.L.; Krystkowiak, P.; Benabid, A.L.; Cornu, P.; Lagrange, C.; Tezenas du Montcel, S.; Dormont, D.; Grand, S.; et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N. Engl. J. Med. 2005, 352, 459–467. [Google Scholar] [CrossRef] [Green Version]
  17. Kupsch, A.; Benecke, R.; Muller, J.; Trottenberg, T.; Schneider, G.H.; Poewe, W.; Eisner, W.; Wolters, A.; Muller, J.U.; Deuschl, G.; et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N. Engl. J. Med. 2006, 355, 1978–1990. [Google Scholar] [CrossRef] [Green Version]
  18. Jamora, R.D.G.; Chang, W.C.; Taira, T. Transcranial Magnetic Resonance-Guided Focused Ultrasound in X-Linked Dystonia-Parkinsonism. Life 2021, 11, 392. [Google Scholar] [CrossRef]
  19. Goto, S.; Lee, L.V.; Munoz, E.L.; Tooyama, I.; Tamiya, G.; Makino, S.; Ando, S.; Dantes, M.B.; Yamada, K.; Matsumoto, S.; et al. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann. Neurol. 2005, 58, 7–17. [Google Scholar] [CrossRef]
  20. Waugh, J.L.; Hassan, A.; Kuster, J.K.; Levenstein, J.M.; Warfield, S.K.; Makris, N.; Bruggemann, N.; Sharma, N.; Breiter, H.C.; Blood, A.J. An MRI method for parcellating the human striatum into matrix and striosome compartments in vivo. Neuroimage 2022, 246, 118714. [Google Scholar] [CrossRef]
  21. Morigaki, R.; Miyamoto, R.; Mure, H.; Fujita, K.; Matsuda, T.; Yamamoto, Y.; Nakataki, M.; Okahisa, T.; Matsumoto, Y.; Miyake, K.; et al. Can Pallidal Deep Brain Stimulation Rescue Borderline Dystonia? Possible Coexistence of Functional (Psychogenic) and Organic Components. Brain Sci. 2020, 10, 636. [Google Scholar] [CrossRef] [PubMed]
  22. Koyama, H.; Mure, H.; Morigaki, R.; Miyamoto, R.; Miyake, K.; Matsuda, T.; Fujita, K.; Izumi, Y.; Kaji, R.; Goto, S.; et al. Long-Term Follow-Up of 12 Patients Treated with Bilateral Pallidal Stimulation for Tardive Dystonia. Life 2021, 11, 477. [Google Scholar] [CrossRef] [PubMed]
  23. Poulen, G.; Chan-Seng, E.; Sanrey, E.; Coubes, P. Deep Brain Stimulation and Hypoxemic Perinatal Encephalopathy: State of Art and Perspectives. Life 2021, 11, 481. [Google Scholar] [CrossRef] [PubMed]
  24. Horisawa, S.; Arai, T.; Suzuki, N.; Kawamata, T.; Taira, T. The striking effects of deep cerebellar stimulation on generalized fixed dystonia: Case report. J. Neurosurg. 2019, 132, 712–716. [Google Scholar] [CrossRef] [PubMed]
  25. Lin, S.; Zhang, C.; Li, H.; Wang, Y.; Wu, Y.; Wang, T.; Pan, Y.; Sun, B.; Wu, Y.; Li, D. High Frequency Deep Brain Stimulation of Superior Cerebellar Peduncles in a Patient with Cerebral Palsy. Tremor Other Hyperkinet. Mov. 2020, 10, 38. [Google Scholar] [CrossRef]
  26. Sokal, P.; Rudas, M.; Harat, M.; Szylberg, L.; Zielinski, P. Deep anterior cerebellar stimulation reduces symptoms of secondary dystonia in patients with cerebral palsy treated due to spasticity. Clin. Neurol. Neurosurg. 2015, 135, 62–68. [Google Scholar] [CrossRef]
  27. Morigaki, R.; Miyamoto, R.; Matsuda, T.; Miyake, K.; Yamamoto, N.; Takagi, Y. Dystonia and Cerebellum: From Bench to Bedside. Life 2021, 11, 776. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Morigaki, R.; Miyamoto, R. Dystonia: Still a Mysterious Syndrome. Life 2022, 12, 989. https://doi.org/10.3390/life12070989

AMA Style

Morigaki R, Miyamoto R. Dystonia: Still a Mysterious Syndrome. Life. 2022; 12(7):989. https://doi.org/10.3390/life12070989

Chicago/Turabian Style

Morigaki, Ryoma, and Ryosuke Miyamoto. 2022. "Dystonia: Still a Mysterious Syndrome" Life 12, no. 7: 989. https://doi.org/10.3390/life12070989

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop